Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial.
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial. Nat Med. 2022 02; 28(2):325-332.
View in:
PubMed
subject areas
Adult
Antigens, CD19
Humans
Immunotherapy, Adoptive
Lymphoma, Follicular
Pilot Projects
Receptors, Antigen, T-Cell
authors with profiles
Peter Riedell